- Home
- IOVA vs SGHC Comparison
IOVA vs SGHC Comparison
Compare IOVA & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IOVA | SGHC |
|---|---|---|
| Founded | 2007 | 2020 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.4B |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IOVA | SGHC |
|---|---|---|
| Price | $8.34 | $10.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $14.40 | ★ $18.67 |
| AVG Volume (30 Days) | ★ 12.3M | 2.5M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $56.63 | $22.34 |
| Revenue Next Year | $43.83 | $8.74 |
| P/E Ratio | ★ N/A | $20.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $8.46 |
| 52 Week High | $15.37 | $15.86 |
Technical Indicators
Market Signals| Indicator | IOVA | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 29.97 | 33.95 |
| Support Level | $7.85 | $10.16 |
| Resistance Level | $9.36 | $11.30 |
| Average True Range (ATR) | 0.98 | 0.36 |
| MACD | -0.75 | 0.02 |
| Stochastic Oscillator | 1.76 | 27.38 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.